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Abstract
Background: Ticks of the species Ixodes ricinus are the main vectors of Lyme Borreliosis and Tick-borne
Encephalitis – two rapidly emerging diseases in Europe. Repellents provide a practical means of protection
against tick bites and can therefore minimize the transmission of tick-borne diseases. We developed and
tested seven different dodecanoic acid (DDA)-formulations for their efficacy in repelling host-seeking
nymphs of I. ricinus by laboratory screening. The ultimately selected formulation was then used for
comparative investigations of commercially available tick repellents in humans.
Methods: Laboratory screening tests were performed using the Moving-object (MO) bioassay. All test
formulations contained 10% of the naturally occurring active substance DDA and differed only in terms of
the quantitative and qualitative composition of inactive ingredients and fragrances. The test procedure
used in the human bioassays is a modification of an assay described by the U.S. Environmental Protection
Agency and recommended for regulatory affairs. Repellency was computed using the equation: R = 100 -
NR/N × 100, where NR is the number of non-repelled ticks, and N is the respective number of control
ticks. All investigations were conducted in a controlled laboratory environment offering standardized test
conditions.
Results: All test formulations strongly repelled nymphs of I. ricinus (100-81% protection) as shown by the
MO-bioassay. The majority of ticks dropped off the treated surface of the heated rotating drum that
served as the attractant (1 mg/cm2 repellent applied). The 10% DDA-based formulation, that produced the
best results in laboratory screening, was as effective as the coconut oil-based reference product. The mean
protection time of both preparations was generally similar and averaged 8 hours.
Repellency investigations in humans showed that the most effective 10% DDA-based formulation (~1.67
mg/cm2 applied) strongly avoided the attachment of I. ricinus nymphs and adults for at least 6 hours. The
test repellent always provided protection (83-63%) against I. ricinus nymphs equivalent to the natural
coconut oil based reference product and a better protection (88-75%) against adult ticks than the synthetic
Icaridin-containing reference repellent.
Conclusion: We found that the 10% DDA-based formulation (ContraZeck®) is an easily applied and very
effective natural repellent against I. ricinus ticks. By reducing the human-vector contact the product
minimises the risk of transmission of tick-borne diseases in humans.
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Background
The most important and commonly found tick in north-
ern Europe is Ixodes ricinus (L.), which acts as a vector of
e.g. several Borrelia species causing Lyme Borreliosis, and
of the Tick-borne Encephalitis (TBE) virus [1].
Tick-borne encephalitis is an endemic disease that is gen-
erally limited to certain geographic foci [2,3]. Up to 5% of
ticks carry the TBE virus in endemic areas of Germany [2].
Thirty per cent of humans bitten by an infected tick
develop symptoms of TBE (headache, fever, nausea) [1,2].
In most cases (90%), the symptoms disappear within
about one week [2]. After an incubation period of up to 20
days, the remaining 10% of cases proceed to the second
stage, which is characterised by the development of a
severe form of meningo-encephalitis associated with the
risk of constant neurological disorders (e.g., paraesthesia)
[1]. A fatal outcome is reported in 1–2% of cases [1,2].
Vaccination against TBE is recommended as a preventive
measure for individuals travelling to or living in risk areas.
Currently, no drug treatment is available for TBE.
Unlike TBE, Lyme Borreliosis is widespread in Europe and
temperate regions of the northern hemisphere [4,5] and
infected ticks can be found at almost all locations, even in
inner city parks [6]. Roughly 5 to 35% of ticks carry bacte-
ria of the genus Borrelia (e.g., B. burgdorferi) [4,7]. The
prevalence rate varies with the stage of tick development:
approximately 20% of adult ticks, 10% of nymphs, and
1% of larvae are infected [7]. When bitten, 20–30% of
humans show a seroconversion, 1.5–6% an infection, but
only 0.3–4% actually develop Lyme Borreliosis [1,7].
Lyme Borreliosis is a multiform and multisystemic disease
rapidly emerging over the last years [4]. In 40–60% of
infected humans, the first manifestation is a spreading red
rash around the bite (erythema migrans), which develops
within a few days to weeks of the tick bite. If left untreated,
meningopolyneuritis, myocarditis or arthritis can occur
[4,7]. Lyme Borreliosis is treated with antibiotics.
I. ricinus ticks are restricted to habitats providing high rel-
ative humidities that do not fall below 80% for extended
periods [8,9]. For host finding, the tick predominantly
adopts the so-called ambush strategy, waiting for a host
on a vantage point, e.g. grass or shrubs [10]. When a ver-
tebrate animal or a human passes by, the tick quickly
clings to the host, then, on the host, searches for an appro-
priate feeding site and starts feeding. Olfactory, visual and
thermal receptors may play different roles in host and
feeding site identification [11-13]. While feeding, I. ricinus
secretes a variety of saliva components with e.g. anticoag-
ulant, antiinflammatory, and immunosupressive action.
These can directly damage the host and favour transmis-
sion and establishment of pathogens [14-18]. An
increased risk of disease transmission with increased
attachment time has been clearly demonstrated, e.g. for B.
burgdorferi  [10,19]. Since certain tick-borne pathogens,
like the TBE virus, are transmitted to the host during the
initial minutes of tick feeding [20], it is important to pre-
vent tick bites completely.
Any person entering the vector's habitat whether for work-
ing or for leisure time activities is at risk. Protection from
tick bites is best achieved by avoiding infested habitats,
wearing protective clothing, and using tick repellent
[4,21]. A repellent is defined by the Environmental Pro-
tection Agency of the United States as a 'pesticide product
that causes insects to be driven or kept away from an iden-
tified area' [22]. In a broader and widely used sense, a
repellent is a product intended to reduce the rate of biting
from blood-sucking arthropods [23]. Given that a single
bite from an infected arthropod can result in transmission
of disease, a tick repellent must be able to prevent ticks
from attaching to the skin. Unlike insecticides, repellents
usually do not kill but rather prevent contact between the
arthropod and the host and, as a consequence, can mini-
mise the risk of acquiring tick-borne infections [4,24]. An
ideal repellent should be effective, easy to apply and non-
toxic to vertebrates, especially humans.
For use on skin, products containing N, N-diethyl-3-
methylbenzamide (DEET) have been widely used for dec-
ades to protect against ticks and biting flies. Recently
developed arthropod repellents, such as 1-methyl-propyl-
2-(hydroxyethyl)-1-piperidinecarboxylate (picaridin),
ethyl butylacetylaminopropionate (EBAAP), and (1S,
2'S)-2-methylpiperidinyl-3-cyclohexene-1-carboxamide
(SS220) were also shown to effectively repel ticks/reduce
the risk of tick bites [24-28]. However, concern about
some serious toxic effects in humans and eco-toxicologi-
cal problems associated with DEET-containing repellents
has revived interest in plants as sources of natural-based
repellents for protection [29-34].
The biocidal product (ContraZeck®) was developed and
manufactured by Dr. R. Pfleger GmbH (Germany) to repel
I. ricinus ticks. The active ingredient, dodecanoic acid
(DDA), is a naturally occurring carboxylic acid that is the
main acid in coconut oil and palm kernel oil, both of
which are commonly used in foodstuffs. This saturated
fatty acid is also a natural component of plant and animal
tissues. The repellency of 10% DDA has been validated
and patented [35]. We tested a variety of different topical
10% DDA-based formulations for their tick-repelling effi-
cacy and tolerability during the process of ContraZeck®
research and development. The present paper describes
the results of this laboratory screening process and
presents the results of comparative repellency studies of
the ultimately selected 10% DDA-based formulation, nowParasites & Vectors 2008, 1:8 http://www.parasitesandvectors.com/content/1/1/8
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available under the trademark ContraZeck®, versus refer-
ence products in humans.
Methods
All tests were conducted by IS Insect Services GmbH in
Berlin, Germany. The test methods have been described
previously [36-38].
Moving-object bioassay (laboratory screening)
Ticks
Laboratory screening tests were performed using unfed I.
ricinus nymphs that were collected from different field
sites in Berlin forest areas. All ticks were maintained at a
shadowed outdoor site in glass vials within desiccators at
a relative humidity of about 90%, natural temperature
and photoperiod known to be suitable for the develop-
ment and life cycle of I. ricinus [39]. Ticks were taken
directly from the outdoor containers to the laboratory and
acclimated to room temperature for about one or two
hours before testing. Longer acclimation periods of up to
two weeks were required in winter.
Test procedure
In the Moving-object (MO) bioassay, warmth and motion
are used as attractants stimulating the natural tick behav-
iour of clinging to a passing host under controlled labora-
tory conditions. The apparatus used for these experiments
was developed and described by Dautel et al. [36]. Briefly,
a slowly rotating vertical drum is heated to a surface tem-
perature of 35–37°C, which is regularly monitored by a
remote infrared thermometer. A piece of filter paper (5 ×
10 cm) fixed at an elevated position on the drum serves as
the tick attachment site. Ticks attracted to the warmth
approach the drum on a horizontally positioned glass rod
that ends directly in front of the drum at a distance where
the tick cannot reach the drum surface by its forelegs. As
the drum rotates, however, the elevated surface of the
drum covered by filter paper passes periodically by and
the tick is able to cling to that surface and transfer to the
drum. To test for repellency, the investigator applies a test
substance to the filter paper and records whether or not
the tick approaches and transfers to the drum and thereaf-
ter remains on the treated filter paper or drops off. The
duration of each step of tick behaviour was measured to
reveal more subtle repellent effects. The strength of this
assay is that different compounds, formulations or prod-
ucts can be compared under standardised laboratory con-
ditions, while confirming that the ticks under
investigation are definitely in a natural host-seeking
modus.
General test conditions
Prior to actual testing, a control run (blank test) was per-
formed with 30 nymphal ticks without repellent but
under otherwise identical test conditions. This control
served to demonstrate sufficient activity of the ticks on the
test day. The filter paper on the drum attachment site was
then treated with one of the 10% DDA-based topical for-
mulations or 10% DDA in ethanol (positive control).
Each experimental run was carried out with 30 ticks, and
each tick was only tested once. Since host-seeking behav-
iour is subject to temporal variation, experiments with
control and test ticks were performed on the same day.
Only active ticks that climbed voluntarily out of their glass
vial after the investigator opened the vial were used for the
tests. Using a fine brush, the ticks were placed individually
on the glass rod with their anterior end facing the drum ≈
1.5 cm away from the tip. All tests were performed under
standardised conditions of room temperature (19–23°C),
relative humidity (30–65%), and drum surface tempera-
ture (35.5–37.0°C).
Criteria assessed
(1) Tick behaviour. Each tick was graded for the following
steps of host location:
a) Did the tick proceed to the drum? (YES/NO)
b) Did the tick attach to the treated or untreated elevated
filter paper (attachment site)? (YES/NO)
c) Did the tick drop off the drum? (YES/NO)
(2) Time course of tick activity. The following times were
recorded:
a) Time required for the tick to reach the tip of the glass
rod, starting from the time it crossed a mark 1 cm from the
tip.
b) Time required for the tick to climb from the tip of the
glass rod to the elevated filter paper.
c) Time that the tick remained on the attachment site.
During each time interval a), b) and c), each tick was
monitored for a maximum of 2 minutes. Ticks that did
not move during the maximum test period were removed
from the experiment and the time for this step was logged
as 120 seconds.
Products tested
10% dodecanoic acid and seven 10% DDA-based topical
formulations were investigated. All products tested were
manufactured in compliance with the quality require-
ments of the current European Pharmacopeia (Ph. Eur.)
in terms of identity, purity and content. 10% dodecanoic
acid in ethanol was sprayed onto the elevated filter paper
and the DDA-based formulations (lotions) were evenly
applied to the filter paper with a roller. The paper wasParasites & Vectors 2008, 1:8 http://www.parasitesandvectors.com/content/1/1/8
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weighed before and after application of each test product
to determine the applied dose. The MO-bioassay was per-
formed using 5 × 10 cm strips of this filter paper. In each
test, three such filter papers were assayed with 10 ticks
each. The quantity of repellent applied per test was about
1 mg/cm2, corresponding to approximately 0.1 mg DDA/
cm2. After this preliminary screening, the repellency of the
10% DDA-based formulation found to be most accepta-
ble was compared to that of Zanzarin® Bio-Hautschutz
Lotion (Engelhard Arzneimittel, Germany), a commer-
cially available, coconut fatty acid-based tick repellent.
Statistical analysis
The G-test [40] was used to test for differences in tick
behaviour, such as the number of nymphs transferring to
the rotating drum or dropping off. Statistical testing was
conducted for differences between times required for spe-
cific behavioural steps using a one-way ANOVA and sub-
sequent Student-Newman-Keuls test. P-values < 0.05 were
regarded as significant. Data sets were analysed using the
software package SPSS for Windows. The repellency of
each test product was determined based on the number of
ticks that: (1) did not approach the drum, (2) did not
attach to the drum, and (3) dropped off the treated filter
paper of the drum. Ticks fulfilling these criteria were clas-
sified as "repelled". Relative repellency (R) was computed
using the equation R = 100-NR/Nx100, where NR is the
number of non-repelled test ticks and N is the respective
number of (non-repelled) control ticks.
Tests in humans
Two small-scale trials in humans were then conducted to
compare the repellent activity of the selected 10% DDA-
based formulation (ContraZeck®)
A. to that of the natural coconut-oil based repellent Zan-
zarin®Bio-Hautschutz Lotion (Engelhard Arzneimittel,
Germany) using I. ricinus nymphs
B. to that of the synthetic Icaridin-containing repellent
Autan® Family Zeckenschutz (Johnson Wax GmbH, Ger-
many) using adult I. ricinus.
Disease-free, laboratory-reared ticks were used in all eval-
uations. The age of the nymphs in trial A was 5 months (n
= 300) and 1.5 years (n = 700). The adult ticks in trial B
were between 6 and 7 months (after moulting) old; their
last blood meal was 8 to 9 months earlier (as nymphs).
The ticks were maintained in a shadowed outdoor site
within glass vials in desiccators at a relative humidity of
90%, normal temperature and photoperiod. One week
before testing started, they were randomised and accli-
mated to room temperature at 90% relative humidity with
a 16:8 h light:dark cycle.
For each study, a total of six volunteers (3 males and 3
females) aged 24 to 45 years (trial A) and 24 to 48 years
(trial B) were tested in the controlled laboratory environ-
ment. During the tests the temperature was kept at a mean
of 22.3 ± 1.2°C, a relative humidity of 58.9 ± 9.0%.
The test procedure used in the human bioassays was
developed by Dautel [37]. It is a modification of an assay
described by the U.S. Environmental Protection Agency
and recommended for regulatory affairs for laboratory
tests with volunteers [22]. The left and right lower leg of
each volunteer was treated with one of the respective test
products alternately on two different days. The surface
area of each lower leg (test area) was calculated as the
product of lower leg length (mean of two measurements
of distance from the hollow of the knee to the heel lateral
to the knee and on anterior aspect of each leg) and leg cir-
cumference (mean of 5 measurements taken at the ankle
and knee and three equidistant points between). These
measurements were used to calculate the amount of repel-
lent applied per unit surface area (mg/cm2). The target
dose of repellent, as recommended in the OPPTS
810.3700 product performance test guidelines of the U.S.
Environmental Protection Agency, was 1.67 mg/cm2 [22].
The amount of test product actually applied was deter-
mined by subtraction of before and after product weight
measurements.
The volunteers were instructed to avoid coffee, tea and fra-
grance products on the day of testing. Immediately prior
to treatment, each person washed the shaved leg with
unscented (fragrance free) soap, rinsed it with water,
cleaned it two times with a cloth soaked with 70% etha-
nol, rinsed the leg again with water and dried it with a
towel. The volunteers applied and evenly distributed the
weighed test product (~1.6 mg/cm2) to the entire test area
using a gloved hand. White Vaseline was applied to the
underside of an untreated copper disk (diameter: 3 cm,
thickness: 0.1 mm), which was positioned in the centre of
the treated skin area using forceps. With the aid of a sten-
cil, a 13 cm diameter circle was marked around the copper
disk. The ticks were applied to the lower legs (held in the
vertical plane) of the seated volunteer. Thirty minutes
after repellent application, two hungry ticks (nymphal (A)
or adult (B) stages of I. ricinus) were placed on the
untreated copper disk and observed for 5 minutes (maxi-
mum). The investigator recorded (1) whether the ticks
crawled onto the treated skin or not, (2) whether the ticks
dropped off the disk or skin, (3) whether the ticks crawled
a distance of at least 5 cm (to the circle mark), and (4)
how long it took the ticks to reach the mark. If they
crossed the mark, the direction of motion (up, down, or
horizontal) was also recorded in order to distinguish pos-
sible subtle repellent effects. Ticks that crawled onto theParasites & Vectors 2008, 1:8 http://www.parasitesandvectors.com/content/1/1/8
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treated skin area and crossed the circle mark were classi-
fied as non-repelled, and those that did not as repelled.
At the start of each test, two ticks were placed together on
the same disk, observed for 5 minutes, and then replaced
with two new, untested ticks making a total of 12 ticks
(adults: 6 female and 6 male ticks) per 30-minute cycle.
Nymphs and adults were tested at times 30–60 min., 90–
120 min., 150–180 min., 210–240 min., and 330–360
min after test product application.
Prior to product testing, a negative (untreated) control run
with 12 ticks/volunteer was performed without repellent
but under otherwise identical conditions. This control
served to demonstrate sufficient activity of the ticks on the
test day (criterion: at least 9 of 12 ticks crawled onto the
skin and crossed the circle mark within 5 minutes).
Statistical analysis
The times required for ticks in the different groups to
crawl onto the skin were tested for differences using a one-
way ANOVA followed by the conservative Scheffé test. Sta-
tistical analyses were done using Statistika v. 8.0. Repel-
lency of each product and differences between the
efficacies of the two test products were evaluated by G-test
[40] using the conservative Yate's correction in cases
where samples with ≥ 30 ticks were compared. P-values <
0.05 were regarded as significant. Absolute repellency was
expressed as the percentage of ticks that did not cross the
circle mark on the treated skin (repelled ticks). Repellency
(R) in relation to the control was computed using the
aforementioned equation, where NR is the number of
(non-repelled) ticks that crossed the circle mark and N is
the respective number of (non-repelled) control ticks.
Results
Moving-object bioassay (laboratory screening)
To identify the most effective 10% DDA-based formula-
tion, screening of 7 precursor preparations was performed
using the MO-bioassay with a total of 720 ticks in five
independent studies of comparable design.
Comparison of 10% DDA and the different DDA-based formulations
- Tick behaviour
The heated moving object (drum) proved to be a good
attractant: ≥ 97% of the I. ricinus nymphs approached the
drum in the absence of repellent. When the elevated filter
paper on the drum (attachment site) was treated either
with 10% DDA alone or with one of the DDA-based for-
mulations, 100% and >93%, respectively, of the nymphs
crawled to the tip of the glass rod (Table 1). Therefore, no
distance effect was observed with DDA or any of the DDA-
based formulations.
Fewer ticks clung to the elevated filter paper treated with
either 10% DDA or any of the respective DDA-based for-
mulations than to the untreated filter paper, but the per-
centage of nymphs that transferred to the drum
attachment site was not significantly different from the
controls. In addition, the nymphs that did not cling to the
elevated filter paper showed no typical distance effect in
response to the repellent. Most of them dropped off the
glass rod even when they stretched their forelegs and
touched the attachment site of the moving drum.
The 10% DDA and all of the DDA-based formulations sig-
nificantly repelled those tick nymphs that transferred to
the treated filter paper. Between 75 and 100% of the
nymphs dropped off the treated filter paper within only a
few seconds; this behaviour was significantly different
from that of the controls.
All products tested achieved a relative repellency of 81.4
to 100 per cent. The repellency of 10% DDA (positive con-
trol) was 82.1% in one test and approximately 89% in the
two others. One DDA-based formulation achieved a
repellency of only 81.4%, but the other six formulations
achieved repellency levels of 86 to 100 per cent. Accord-
ingly, the repellency of the six DDA-based formulations
was at least as high as that of 10% DDA.
- Time course of tick activity
The mean times required to reach the tip of the glass rod
and to transfer to the rotating drum did not differ signifi-
cantly between the control and test groups (ANOVA, P >
0.05). Therefore, no distance effect associated with repel-
lent exposure was observed. The tick nymphs stayed
attached to filter paper treated with either 10% DDA or
one of the DDA-based formulations for significantly less
time than on untreated filter paper (ANOVA, P < 0.001).
Most ticks dropped off the treated area within a few sec-
onds. In addition, the nymphs remained on filter paper
treated with the respective DDA-based formulations for
significantly shorter periods than on filter paper treated
with 10% DDA (Figure 1).
Repellency of the selected 10% DDA-based formulation versus 
Zanzarin®
The repellency of the 10% DDA-based formulation that
produced the best results in screening was compared to
that of the reference product Zanzarin® in a further study
using the MO-bioassay. The course of repellency over time
was observed in 210 tick nymphs for a total of 8 hours
after application of the respective test substance (Table 2).
The DDA-based formulation exhibited maximum relative
repellency (100%) 1, 4 and 8 hours after application.
Repellency of the reference product was slightly lower
after 1 hour (96.5%) and also varied over time. However,
both the DDA-based formulation and the reference prod-Parasites & Vectors 2008, 1:8 http://www.parasitesandvectors.com/content/1/1/8
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uct proved to be equally repellent to I. ricinus nymphs
over 8 hours. Ticks spent significantly less time on filter
paper treated with either of the two repellents than on
untreated filter paper. The two repellent formulations did
not exhibit any significant differences in regard to the time
course of tick activity.
Tests in humans
Trial A: Repellency of ContraZeck® versus Zanzarin® against I. 
ricinus nymphs
I. ricinus nymphs were strongly repelled by both the
selected 10% DDA-based formulation and the reference
product Zanzarin® for up to 6 hours after application (G-
values always >38.5, P always < 0.001). Quantitative dif-
ferences in the repellency of the two products between
volunteers were observed. However, both of the two prod-
ucts exhibited statistically significant repellency in all vol-
unteers and at each sampling time.
Figure 2 shows the mean repellency of both products in
tick nymphs in relation to the respective controls over the
whole observation time of 360 minutes after application.
Whereas more than 94% of all control nymphs crawled
onto the untreated skin, both repellents prevented more
than 83% (ContraZeck®) and 94% (Zanzarin®) of them
from crossing the 5 cm circle mark during the first obser-
vation cycle (30–60 min after application). Most of the
nymphs dropped already off the copper disk, a small
number only dropped off the treated skin. No significant
differences in mean repellency were found between the
two products at any time. Both the test formulation and
reference product remained as effective as in the prelimi-
nary experiments.
The percentage of tick nymphs repelled decreased slowly
and moderately over time (up to 6 h), but the repellency
of the test and reference product was always significantly
different from that of the controls. At 6 h, relative repel-
Table 1: Repellent effects of different DDA-based lotion-formulations against I. ricinus nymphs (MO-bioassay)
Project Crawling to the tip of the 
glass rod
Attaching the filter paper on the 
drum
Dropping off the attachment site Repellency [%]
n % n % n % Significance*
Trial 1
Blank test 29 96.7 27 93.1 0 0
10% DDS 30 100 28 93.3 25 89.3 p < 0.001 88.90
Batch 030138 30 100 23 76.7 22 95.7 p < 0.001 96.30
Batch 030142 29 96.7 20 69.0 15 75.0 p < 0.001 81.40
Trial 2
Blank test 29/30 96.7 24/27 82.8/90.0 0/1 0/3.7
10% DDS 30 100 24 80.0 21 87.5 p < 0.001 88.5
Batch 030174 30 100 20 66.7 17 85.0 p < 0.001 87.5
Batch 030175 29/29 96.7/96.7 21/20 72.4/69.0 19/17 90.5/85.0 p < 0.001 91.63/88.5
Batch 030176 28 93.3 22 78.6 20 90.9 p < 0.001 91.63
Trial 3
Blank test 30 100 28 93.3 0 0
10% DDS 30 100 24 80.0 19 79.2 p < 0.001 82.10
Batch 040088 30 100 23 76.7 19 82.6 p < 0.001 85.74
Trial 4
Blank test 30 100 29 96.7 0 0
Batch 040108 30 100 21 70.0 21 100 p < 0.001 100
Batch 050030 30 100 24 80.0 24 100 p < 0.001 100
The quantity of repellent applied per test was about 1 mg/cm2, corresponding to approximately 0.1 mg DDA/cm2. Batch No. 050030 is identical to 
the final product ContraZeck® in terms of the qualitative and quantitative ingredients and fragrances. Batch No. 040088 and Batch No. 040108 are 
identical in terms of the qualitative and quantitative ingredients and fragrances. *Significance in relation to blank test
MO-bioassay Figure 1
MO-bioassay. Mean times (± S.D.) tick nymphs 
stayed attached to the filter paper. The filter paper on 
the attachment site of the rotating drum was treated either 
with 10% DDA (n = 28) or with one of the 10% DDA-based 
formulations (Trial 1: batch no. 030138, n = 23; batch no. 
030142, n = 20). The control run (blank test, n = 27) was 
performed without repellent but under otherwise identical 
conditions. Differences between the control and each of the 
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lency of the DDA-based formulation was 63% in I. ricinus
nymphs compared to 75% for the reference product (dif-
ference not significant).
The test and reference products did not exhibit any differ-
ences with respect to the time required for the ticks to
crawl onto the treated skin or in the direction of their
walk. Control ticks exhibited a strong tendency to crawl
upwards on untreated skin. In contrast, test ticks walking
on treated skin preferred to crawl downwards to escape
the host [37]. A mean 62% of control ticks crawled up and
15% down (the others to the side), whereas only 2
nymphs per test substance crawled up, but 80% (Con-
traZeck®: G = 99.5, P < 0.001) and 50% (Zanzarin®: G =
69.8, P < 0.001) crawled downwards on the treated skin.
In this respect, there were no significant differences
between the test and reference product.
Trial B: Repellency of ContraZeck® versus Autan® Family against 
adult ticks of I. ricinus
Of the two products tested, that containing 10% DDA
provided the most effective protection (relative repel-
lency: 88-75.5%). There was an overall statistically signif-
icant tendency in favour of the 10% DDA-based
formulation (ContraZeck®) when compared with the syn-
thetic Icaridin-containing product (Autan® Family) over all
volunteers and all time points (G = 12.4, P < 0.01). Com-
pared to the controls, both the test product and the refer-
ence product provided statistically significant and long-
lasting protection (88-62%) in all volunteers and at each
time point for up to 6 hours after application (G-values
always >61.9, P always < 0.001) (Figure 3). In terms of rel-
ative repellency, both products were quite similar at 1, 4
and 5 hours after application, whereas there was a statisti-
cally significant difference in repellency between Con-
traZeck® and Autan® Family at 2, 3 and 6 hours (2 h: G =
6.4 (P < 0.05); 3 h: G = 6.4 (P < 0.05); 6 h: G = 4.2 (P <
0.05).
Differences in repellent reaction between male and female
ticks were not observed. There were almost no further dif-
ferences between both products regarding the number of
ticks entering the treated skin or between the walking
directions of such ticks that were not repelled. However,
both products induced more ticks to walk down than in
the controls.
Discussion
The European Parliament classifies substances as "repel-
lents and attractants" (biocidal product-type 19) that are
"used to control harmful organisms (invertebrates, verte-
Table 2: Repellent effects of ContraZeck® and Zanzarin® against I. ricinus nymphs over time (MO-bioassay)
Test formulation Crawling to the tip of 
the glass rod
Attaching the filter paper on 
the drum
Dropping off the attachment site Repellency [%]
n % n % n % Significance
Blank test 30 100 28 93.3 0 0
DDA-based form. 
Batch 040088 – 1 h
30 100 23 75.7 23 100 p < 0.001* p > 0.05** 100
Batch 040088 – 4 h 30 100 25 83.3 25 100 p < 0.001* p < 0.05** 100
Batch 040088 – 8 h 30 100 23 75.7 23 100 p < 0.001* p > 0.05** 100
Reference# – 1 h 28 93.3 23 82.1 22 95.7 p < 0.001* 96.5
Reference# – 4 h 30 100 29 96.7 24 82.8 p < 0.001* 82.1
Reference# – 8 h 30 100 25 83.3 21 84.0 p < 0.001* 85.7
The quantity of the DDA-based formulation (ContraZeck®) applied per test was about 1 mg/cm2, corresponding to approximately 0.1 mg DDA/
cm2. # The reference product Zanzarin® (Bio-Hautschutz Lotion) was applied per test in a concentration of 1.05 mg/cm2.
Significance: *in relation to blank test, **in relation to Zanzarin®. Differences in repellency between both products are significant only 4 hours after 
application.
Test in humans [A]. Relative repellency of ContraZeck® and  Zanzarin® against I. ricinus nymphs Figure 2
Test in humans [A]. Relative repellency of Con-
traZeck® and Zanzarin® against I. ricinus nymphs. Each 
data point in the graph is the mean ± S.D. of relative repel-
lency (with respect to the controls) in six volunteers and of 
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brates), by repelling or attracting, including those that are
used for human or veterinary hygiene either directly or
indirectly" [41]. Dodecanoic acid (DDA), the active sub-
stance in the tick repellent ContraZeck®, is intended for
use on human skin. When applied as a repellent, DDA
therefore indirectly serves as a human hygiene product
used as a preventive measure. Consequently, the respec-
tive DDA-formulation must be classified as a biocidal
product type 19 according to Annex V of Directive 98/8/
EC [41]. The repellent must therefore fulfil several require-
ments to be accepted by regulatory authorities and users.
The results of the presented investigations demonstrate
convincingly that the DDA-based formulation meets
these requirements.
Protection from tick bites
Moving-object bioassay
As clearly demonstrated by laboratory screening, each of
the seven DDA-based formulations tested significantly
reduced the proportion of I. ricinus nymphs attaching to
repellent-treated filter paper on the rotating drum of the
MO-bioassay apparatus. Although a distance effect cover-
ing a few mm or more can be excluded, a small number of
ticks dropped off in the phase of clinging to the drum sur-
face. The majority of ticks, however, dropped off the
treated filter paper within seconds, a behaviour rarely
observed in the controls. This demonstrates a clear repel-
lent effect.
In all experiments, it was clear that the nymphs displayed
their natural host-seeking behaviour during the tests.
Arthropods engaged in host seeking are more difficult to
repel than individuals tested in the absence of any attrac-
tive stimuli [42]. This was shown for ticks using the MO-
bioassay, since DEET could repel I. ricinus nymphs even
from a short distance when there was no attractant availa-
ble, whereas a high proportion of nymphs initially walked
onto the DEET-treated filter paper of the rotating drum
that attracted the ticks by warmth [36]. Thus, the MO-bio-
assay can assess more aspects of repellency than an assay
lacking such an attractive component. This is a major
advantage since repellents used for personal protection
must effectively counteract all the attractive effects of a
potential host [38]. Therefore, the MO-bioassay is consid-
ered a suitable laboratory test system for potential tick
repellents. The good prospective quality of the MO-bio-
assay is further shown by the results of the human studies
that differed only slightly from those of the laboratory
screening.
The fact that most of the nymphs dropped off the treated
filter paper suggests that the tested DDA-based formula-
tions may act as contact repellents. Such contact repel-
lency was proven for the pyrethroid permethrin [43], a
sodium channel blocker that did not repel ticks in the gas
phase [26]. One can suspect that the different DDA-based
formulations either had irritant properties that warded off
the ticks and/or other effects that modified the surface
properties of the treated area. However, from the MO-bio-
assay results it cannot be ruled out that DDA might never-
theless ultimately act in the gas phase at concentrations
that are only high enough immediately above the evapo-
rating surface at 35°C, a temperature close to the melting
point of the substance.
However, irrespective of its mode of action, the proven
repellency of each of the 10% DDA-based formulations
unequivocally demonstrates that this concentration is
adequate for effective protection against tick bites. The test
results also showed that the selected fragrances and inac-
tive ingredients of each product formulation did not rele-
vantly influence the repellent effect of the active principle,
dodecanoic acid.
The efficacy of the selected DDA-based formulation was
comparable to that of the reference product Zanzarin®
(Bio-Hautschutz Lotion), which had already been inde-
pendently verified as being very effective against hard ticks
[44]. In these previous investigations, the coconut oil-
based product Zanzarin® was identified as the most effec-
tive product currently available on the market.
Test in humans [B]. Relative repellency of ContraZeck® and  Autan® Family against adult I. ricinus ticks Figure 3
Test in humans [B]. Relative repellency of Con-
traZeck® and Autan® Family against adult I. ricinus 
ticks. Each data point in the graph is the mean ± S.D. of rela-
tive repellency (with respect to the controls) in six volun-
teers and of 12 adult ticks tested in each volunteer (n = 72) 








30-60 90-120 150-180 210-240 270-300 330-360















ContraZeck Autan FamilyParasites & Vectors 2008, 1:8 http://www.parasitesandvectors.com/content/1/1/8
Page 9 of 11
(page number not for citation purposes)
Tests in humans
The repellency of the 10% DDA-based formulation found
to be the most acceptable in laboratory screening was
additionally compared to that of two reference products
in humans. Under the described standardised test condi-
tions [38], nymphal and adult life stages of I. ricinus were
strongly deterred from crossing uncovered skin treated
with either the test or one of the reference products for at
least six hours. Hereby, the DDA-based preparation was
found to be just as effective as the natural reference prod-
uct Zanzarin® in repelling I. ricinus nymphs. Comparable
experimental conditions were used to test eight other
commercially available repellents against ticks of the spe-
cies I. ricinus in a previous study with volunteers [37]. Two
products prevented more than 90% of the nymphs from
crawling a distance of 5 cm over treated skin (arm or leg)
during the observation period of 15 to 45 min after repel-
lent application. The other six products either repelled
lower proportions of the ticks (70–80%) or showed no
repellent effect at all (<50%). Accordingly, both the DDA-
based formulation and the reference product used in the
present human study showed comparable efficacy against
I. ricinus nymphs as the most effective repellents in the
previous study.
The selected DDA-based formulation ContraZeck® was
also proved to be highly effective against adult ticks of I.
ricinus. Overall, there was a statistically significant ten-
dency in favour of ContraZeck® when compared with the
synthetic reference product Autan® Family over all volun-
teers and all time points.
The present tests in humans showed, that ticks need not
necessarily come into direct contact with the tested formu-
lation in order to be repelled by them as the great majority
of the ticks dropped off the copper disk before they had
come in contact with the treated skin.
Another criterion, albeit for a more subtle repellent effect,
may be the direction the tick crawls on treated skin. Once
on a host, I. ricinus nymphs and adults normally prefer to
crawl upwards when seeking a feeding site. In the present
assays, however, most of the ticks that crossed repellent-
treated skin walked downwards, irrespective of the type of
repellent used. This finding may signify that such ticks
that were not classified "repelled" according to test criteria
might nevertheless have had the motivation to walk off
the host.
Theoretically, field tests with volunteers are the preferable
method for evaluation of repellents for human use [42],
but they are presumably unethical in Europe because they
pose the risk of transmission of tick-borne diseases. Fur-
thermore, conducting such studies indoors makes it pos-
sible to reduce potential confounding variables, such as
density of tick population, the level of the ticks' hunger,
temperature, humidity, and the wind speed that can make
it difficult to analyse comparisons among products made
in outdoor-field trials [38]. Field tests require therefore
high numbers of test replications. The volunteer studies
used here, in contrast, allow direct observation and quan-
tification of tick behaviour under more standardised con-
ditions, including minimal risk of volunteers to acquire
tick-borne diseases. The ratio for using this specific test in
favour of the EPA procedure is discussed in Dautel [37].
The observed inter-individual differences in repellency are
quite normal considering that only a small number of vol-
unteers were tested and that the attractiveness of humans
to other blood-sucking arthropods also varies [45,46].
In conclusion, the DDA-based formulation convincingly
meets the requirements of an effective repellent and pre-
vents ticks from piercing exposed skin. This can be
achieved either by preventing the tick from clinging to the
body at all or by inducing the tick to drop off once it
comes in contact with treated skin.
Duration of repellency
The investigations showed that the tested DDA-based for-
mulations provided significant tick bite protection for up
to 6 hours in humans and up to 8 hours in the laboratory-
testing device. The mean protection times of ContraZeck®
and the reference products against bites of I. ricinus
nymphs and adults were comparable. Under field condi-
tions, however, the degree of protection can be influenced
by several factors, including environmental ones, like
habitat structure, weather, tick activity/density, and host-
typical properties like the degree of human exercise, the
kind of clothes or fragrances used, or the quantity of repel-
lent applied [24,37].
Tolerance
No toxic or allergic reactions to dodecanoic acid have
been reported, and DDA was shown to be safe when used
on skin. The Cosmetic Ingredient Review [47] concluded
that DDA is safe in cosmetic use up to a concentration of
25%.
Conclusion
We conclude that the DDA-based formulation Con-
traZeck® is an easily applied and effective repellent against
nymphal and adult life stages of I. ricinus. The product
can be expected to provide a safe as well as a long-lasting
repellent effect under circumstances in which it is crucial
to be protected against tick bites that might transmit dis-
ease.Parasites & Vectors 2008, 1:8 http://www.parasitesandvectors.com/content/1/1/8
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